Congratulations to the team at Aroa Biosurgery, which is listing today on the ASX with a valuation of AUD$225mil. Originally known as Mesynthes, Aroa has been developing wound dressings and soft tissue regeneration products since 2008. Getting the company all the way through to exit is a huge milestone for everyone involved, with congratulations in particular to Movac for putting a lot of time and effort into guiding and shepherding the company through to this stage.

Read more here: https://www.afr.com/companies/healthcare-and-fitness/fundies-flock-to-aroa-biosurgery-float-20200721-p55e0r

and the Aroa Biosurgery press release here: https://aroabio.com/blog/news_article/aroa-biosurgery-to-list-on-the-asx-in-225m-ipo